Welcome to Nordic Epilepsy Academy live webcast expert sharing session
September 24th, 2024
12:05–12:50 and 16:00–16:45 (CET)
Do you have any questions? Please contact:
Anna Östensson, Medical Science Liaison Sweden
anna.oestensson@angelinipharma.com
We’ll be happy to have your registration no later than September 20th
Researchers from Lund University, Sweden, have discovered higher levels of immune proteins in the blood before and after an epileptic seizure. The possible biomarkers can be identified using a simple blood test. Diagnosing epilepsy can currently be resource intensive, and distinguishing it from other conditions sometimes very challenging. The research team has compared epileptic seizures with what are known as psychogenic non-epileptic seizures. Psychogenic seizure is a psychiatric diagnosis that manifests itself through clinical symptoms that can easily be mistaken for epilepsy and thereby treated with epilepsy medication without success. That is why there is a great need to be able to distinguish between the conditions more easily. Better diagnostic methods as soon as the patient seeks medical care after suspected seizures will increase the quality and efficiency in epilepsy practice.
Christine Ekdahl Clementson is Associate professor, Principal investigator at Division of Clinical Neurophysiology and Lund Epilepsy Center, Dept Clinical Sciences, Lund University. She is also a Senior Consultant in Clinical Neurophysiology at Skåne University Hospital. Her focus is on advanced epilepsy investigations, and she has led the research study.
Nordic Epilepsy Academy is a scientific medical educational program developed for neurologists & epileptologists specialized within Epilepsy in the Nordics. The sessions provided will offer deep-dive scientific sessions and possibility to interact and discuss with experts in depth.
Warm welcome to join the meeting!
Nordic Epilepsy Academy – Angelini Pharma Medical Education. Education to healthcare professionals within epilepsy. This session is free of cost and remuneration to speaker is paid for by Angelini Pharma Nordics.
Medical Science Liaison (MSL), Sverige Mobile: +46 73 405 76 45 anna.oestensson@angelinipharma.com
Medical Science Liaison (MSL), Finland Mobile: +358 40 8386399 marko.luostarinen@angelinipharma.com
Medical Science Liaison (MSL), Norway and Denmark Mobile: +47 41 67 08 04 charlotte.andersen@angelinipharma.com
SWEDEN:
Fortbildning för sjukvårdspersonal verksamma inom epilepsi med kopia till huvudman samt berörd läkemedelskommitté. Detta är en kostnadsfri utbildning. Arvoden till föreläsare bekostas av Angelini Pharma Nordics
DENMARK:
Invitationen framsendes iflg gældende aftaler mellem LIF og regionerne. Mødet er anmeldt til ENLI, inden arrangementets afholdelse, og er efter Angelini Pharma Nordics opfattelse i overensstemmelse med reglerne på området, selvom arrangementet ikke på forhånd er godkendt af ENLI.
NORWAY:
Ved påmelding til dette arrangementet, erklærer du som deltager at reglene som gjelder din arbeidsplass er fulgt og at tillatelse er innhentet fra arbeidsgiver
Angelini Pharma Nordics AB
Östermalmstorg 1,
114 42 Stockholm
July 2024, NO2524NP, FI2523NP, DK2522NP, SW2521NP